FITC anti-mouse CD19 Antibody
- 产品名称：
- FITC anti-mouse CD19 Antibody
- 产品类别：
- 抗体
- 产品编号：
- 152403
- 产品应用：
- 152403
- Verified Reactivity
- Mouse
- Antibody Type
- Monoclonal
- Host Species
- Rat
- Immunogen
- Transfected k562 cells expressing the extracellular domain of murine CD19.
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
- Preparation
- The antibody was purified by affinity chromatography and conjugated with FITC under optimal conditions.
- Concentration
- 0.5 mg/ml
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
- Application
-
FC - Quality tested
- Recommended Usage
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.125 ?g per million cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.
- Excitation Laser
- Blue Laser (488 nm)
- Application Notes
Additional reported applications (for the relevant formats) include: blocking1,2 and immunoprecipitation1.
- Application References
(PubMed link indicates BioLegend citation) -
- Krop I, et al. 1996. Eur. J. Immunol. 26:238. (FC, Blocking, IP)
- Abraham P, et al. 2014. Clin. Exp. Immunol. 175:181. (Blocking)
- Product Citations
-
- Chei S, et al. 2020. Front Nutr. 7:583186. PubMed
- Zhou R, et al. 2022. EBioMedicine. 75:103762. PubMed
- Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
- Miller CM, et al. 2020. J Virol. 94:00:00. PubMed
- Hu HJ, et al. 2020. Cell Death Dis. 1.168055556. PubMed
- Zhao J, et al. 2019. Nat Commun. 10:899. PubMed
- Suzuki Y, et al. 2022. Mol Ther Nucleic Acids. 30:226. PubMed
- Liang Y, et al. 2020. J Immunol. 204:2984. PubMed
- Molina-Sanchez P, et al. 2020. Gastroenterology. 2203:159. PubMed
- Davis FM, et al. 2019. Arterioscler Thromb Vasc Biol. 39:2353. PubMed
- Ostendorf BN, et al. 2020. Nat Med. 26:1048. PubMed
- Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
- Jassinskaja M, et al. 2021. Cell Reports. 34(12):108894. PubMed
- Cha SE, et al. 2021. Oncoimmunology. 10:1899469. PubMed
- Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
- Deng M, et al. 2020. Nat Commun. 11:2193. PubMed
- Pardy RD, et al. 2021. Nat Commun. 12:4051. PubMed
- Tavazoie MF, et al. 2018. Cell. 172:825. PubMed
- Zhou G, et al. 2019. FASEB J. 33:11396. PubMed
- Subramanian K, et al. 2019. Nat Microbiol. 4:62. PubMed
- Xu P, et al. 2020. Cancer Immunol Res. 8:1193. PubMed
- Niderla-Bielinska J, et al. 2021. Int J Mol Sci. :22. PubMed
- Dong X, et al. 2022. Front Immunol. 13:896472. PubMed
- Gomzikova MO, et al. 2020. Pharmaceutics. 12:00. PubMed
- Silva HM, et al. 2019. J Exp Med. 216:786. PubMed
- Tanegashima K et al. 2017. EBioMedicine. 24:247-256 . PubMed
- Whiteley AM et al. 2017. eLife. 6 pii: e26435. PubMed
- Jiang W, et al. 2021. Cell Rep. 37:110112. PubMed
- RRID
- AB_2629812 (BioLegend Cat. No. 152403) AB_2629813 (BioLegend Cat. No. 152404)
- Structure
- Ig superfamily, associates with CD21 and CD81, 95 kD.
- Distribution
-
Pro-B cells to mature B cells (during development), follicular dendritic cells.
- Function
- Modulates B cell activation and differentiation.
- Ligand/Receptor
- CD21, CD81, Leu-13.
- Cell Type
- B cells, Dendritic cells
- Biology Area
- Costimulatory Molecules, Immunology
- Molecular Family
- CD Molecules
- Antigen References
-
1. Fearon DT. 1993. Curr. Opin. Immunol. 5:341.
2. Krop I, et al. 1996. Eur. J. Immunol. 26:238.
3. Krop I, et al. 1996. J. Immunol. 157:48.
4. Tedder TF, et al. 1994. Immunol. Today 15:437.
- Gene ID
- 12478 View all products for this Gene ID
- UniProt
- View information about CD19 on UniProt.org
